The Clinical Operations Team at Apexigen is responsible for the planning, execution, and management of clinical trials evaluating novel antibody therapeutics for cancer treatment. Led by the Chief Medical Officer, the team ensures compliance with regulatory standards and oversees oncology Phase II and III studies, managing timelines, budgets, and stakeholder communication to drive the successful advancement of immuno-oncology products.
View all